A new drug for the most common types of Mesothelioma lung cancers

The scientists tested a new drug to determine the extent of its ability to initial treatment for the most common types of lung cancers.

And know the name of the new drug Tarceva, which is produced by Roche and Genntek Osei, was finally adopted in the United States.

June British scientists at the Center for Research on Cancer and the University of London University Kdig to try the drug on 664 patients with advanced lung cancer cells, a type of non-small can be treated by conventional means.

Researchers say the President, Dr. Siu Meng Li conventional chemotherapy did not help very much in the treatment of advanced lung cancer cells that neoplasms quickly become resistant to treatment, while chemotherapy does not distinguish adequately between the cells Almtsrtunp and other sound effects in addition to the side difficult for patients with lung cancer that Ikavhoha successfully.

Tarceva is one of the new cancer drugs known as medicines, “smart” as the pill only in the day that used to impede the movement of the patient molecule known as “the future of the human growth factor”, which convey the orders to the cells to grow and make it fall.

The scientists in addition to monitoring the evolution of the situation analysis of patient tumors and determine the quality and the proportion of the molecule in the body to determine the extent of the patient’s response to the drug in question.

Meng Li says, “The testing of such a large-scale will play a decisive role in the evaluation of the new smart cancer drugs and to have access to the most effective types and distribution to the clinics as soon as possible.”

States that lung cancer is the most common cancer in the world, affecting 900 thousand men and 330 thousand women in the world each year, according to the international body of research in the field of cancer.

The proportion of cases of lung cancer than non-small cell to 75% of all cases of lung cancer, and return to the diagnosis of the disease are often in the later stages.

The other hand, will test the drug in 100 health centers in Britain, where patients will be selected at random and given some of Tarceva, while giving others a similar bogus pills in addition to radiotherapy, if found necessary, as the scientists hope to complete those tests within a year from now.

Meng Li says, “If the drug proved successful, it will be an ideal treatment.”
Source: Reuters

This Informations Collected And Translated From Arabic Language By Mesothelioma Guide